Navigation Links
Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
Date:12/7/2009

M.D. added, "While SOLESTA is already available in Europe, we are confident that the publication of the study will enhance the adoption of this important treatment among the European professional community to help patients suffering from this condition."

About the Study

The Investigational Device Exemption Study was a randomized, subject and evaluator blinded, controlled, multi-center study designed to evaluate the efficacy and safety of SOLESTA for the treatment of fecal incontinence. More than 200 patients suffering from fecal incontinence were included in 13 study sites throughout the United States and Europe. Primary endpoints of the study looked at the efficacy of both groups at six months as well as evaluated the durability of response in the SOLESTA treatment group at 12 months.

About SOLESTA(TM)

SOLESTA is approved for use in Europe and Canada as an injectable treatment for fecal incontinence. SOLESTA is a biocompatible substance composed of stabilized hyaluronic acid, including dextranomer, manufactured according to Q-Med AB's patented technology, NASHA(TM). The treatment is a minimally invasive, in-office procedure. SOLESTA was developed in 2004 by Q-Med AB in Sweden. Oceana Therapeutics acquired the global rights to market and sell SOLESTA in June 2009.

About Q-Med AB

Q-Med is a medical device company that primarily develops, manufactures, markets and sells medical implants. Most of the products are based on the company's patented technology, NASHA(TM), for the production of stabilized non-animal hyaluronic acid. The company today has approximately 650 co-workers in 20 countries, with approximately 400 at the company's head office and production facility in Uppsala. Q-Med had sales of 1,272 MSEK during 2008. Q-Med AB is listed in the Mid Cap segment of the NASDAQ OMX Nordic.

About Oceana Therapeutics, Inc.

Oceana Therapeutics was
'/>"/>

SOURCE Oceana Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014  Corporate libraries are constantly being ... advancements in technology and how to cope with flat ... the pharmaceutical and medical device industries are increasingly finding ... and services they provide. According to ... are many forces of change that leading corporate libraries ...
(Date:7/25/2014)... 2014  In today,s marketplace, launching multiple products for ... as is managing a portfolio of products in the ... - or even preferable - to pool resources to ... combine resources and activities, and what marketing and sales ... just a few of the dilemmas facing pharmaceutical sales, ...
(Date:7/25/2014)... DALLAS , July 25, 2014 /PRNewswire-iReach/ -- "Australia ... market data on the Australia Capsule Endoscopy Systems market. ... volume (in units) and average prices (in US dollars) ... , Capsule Endoscopes , ... The report also provides company shares ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... LAS VEGAS, Oct. 26 Cord Blood America, Inc ... ), the umbilical cord blood stem cell preservation company ... cells to families nationwide and internationally, today announced its Chairman, ... Company,s stem cell collection business in China in an interview ...
... sectors -- HONG KONG, Oct. 26 /PRNewswire-Asia/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
Cached Medicine Technology:Cord Blood America Updates Its Stem Cell Collection Business in China 2Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors 2Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors 3Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors 4Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors 5Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors 6Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors 7Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors 8Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors 9
(Date:7/26/2014)... Studio B Dental in Toronto now offers All-on-Four dental ... a Day, gives patients the opportunity to replace their damaged ... whites with very little recovery time and no bone grafting. ... like natural teeth, and require no special care beyond the ... is one of the premiere dental experts on All-on-Four implants ...
(Date:7/26/2014)... OH (PRWEB) July 26, 2014 The U.S. ... guidelines list that includes a new medication guide for AndroGel ... a serious side-effect of taking the topical low testosterone medication, ... that AbbVie Inc., the makers of the low testosterone theapy ... symptoms of pain, swelling or redness as signs of a ...
(Date:7/26/2014)... Another DePuy Pinnacle hip lawsuit against Johnson & Johnson and ... & Schulte LLC. This DePuy Pinnacle hip lawsuit ... Ohio man who alleges that he has had pain and ... Pinnacle Hip implant in 2008. According to this hip replacement ... complex and risky revision surgery to replace the metal-on-metal components ...
(Date:7/26/2014)... We’ve all heard about athletes ... concussions in the workplace are among the most ... risk of head injury are:, ... officers ,     Race car drivers , ... , “Most workplace head injuries ...
(Date:7/26/2014)... According to the Metabolic Enhancement Training ... comprehensive bodybuilding program that helps men lose body fat ... . The program also instructs men how to melt ... Vkool reveals in its review that this program includes ... men get ripped and jacked at the same time. ...
Breaking Medicine News(10 mins):Health News:Studio B Dental Improves Patient Smiles with All-on-Four Dental Implants 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 3Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 5Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 5Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 2Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 3Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3
... such as not using condoms or having sex with ... sexually transmitted diseases, but perhaps not as much as ... researchers say. , The findings, which UF and University ... Sexually Transmitted Diseases , could help health-care providers ...
... 3 eDiets.com, Inc. (Nasdaq: DIET ... healthy lifestyle solutions, today announced that it received a notice ... of the Company,s listed securities has fallen below $35 million, ... Market, in compliance with NASDAQ Marketplace Rule 4310(c)(3)(B). The ...
... less apt to include adult smokers, study finds, , , FRIDAY, ... more secondhand smoke than their wealthier counterparts, a new study ... "poor kids are far more likely to live with multiple ... Michael Weitzman, a professor of pediatrics at New York University. ...
... awarded $15,000 for envisioning the ,home of the future, ... At the Embedded Systems Conference (ESC) Silicon Valley 2009 ... of the Microsoft Windows Embedded SPARKs Will Fly developer ... innovation among the embedded hobbyist and academic communities. The ...
... the growing number of Pennsylvanians who are trying to ... in federal cigarette taxes, the Department of Health today ... www.determinedtoquit.com ."The average smoker makes between five and ... have support are more likely to succeed," said Secretary ...
... risk from overdosing following the surgery, study found , , FRIDAY, ... to one in five deaths among people who have had ... relieve lower back pain. , Among this group, middle-aged ... risk of either accidental or suicidal analgesic poisoning compared to ...
Cached Medicine News:Health News:Partner behavior better predicts STD risks 2Health News:Partner behavior better predicts STD risks 3Health News:eDiets.com(R) Receives NASDAQ Notice Regarding Market Value of Listed Securities 2Health News:eDiets.com(R) Receives NASDAQ Notice Regarding Market Value of Listed Securities 3Health News:Poor Kids Exposed to More Secondhand Smoke 2Health News:Poor Kids Exposed to More Secondhand Smoke 3Health News:Microsoft Windows Embedded Announces Winner of SPARKs Will Fly Developer Contest 2Health News:Pennsylvania Department of Health Helps Smokers Trying to Quit in Wake of Federal Cigarette Tax Hike 2Health News:Post-Op Painkillers Tied to Deaths After Spinal Fusion 2
... have a positive and negative inoculated well, ... these slides, perform QC and sample staining ... education and training programs by testing QC ... on one slide! KWIK-QC slides contain the ...
Microbiology QC Slides come with one or two droplets of an air-dried and methanol-fixed microorganism, or a single smear containing a designated microorganism population....
... Plate Capability The Equalizer 384 includes ... and equal tip spacing, choice of two software ... addition, this model allows you to evenly space ... accessing many gels and for use with 384 ...
Each slide contains a high yield of concentrated C. parvum oocysts within the positive control well. A negative control well is also included....
Medicine Products: